Gabriela A.: New FDA Approval Advances the Future of Dried Plasma
Gabriela A., Project Coordinator at UT Health San Antonio, shared a post on LinkedIn:
”The FDA’s recent approval of ‘Ezplaz’, the first-ever-dried plasma product licensed in the United States, marks a major advancement in trauma care, particularly for military, emergency response, and other austere environments where traditional blood products are difficult to store and transport.
This milestone highlights the growing momentum behind blood preservation research, including TRC4-supported work at UTAustin, where investigators are exploring innovative thin-film freeze-drying approaches that could help shape the future of blood product storage, transport, and use in austere environments.
It’s exciting to see innovations once considered aspirational become reality, while groundbreaking research across The University of Texas System continues to transform bold ideas into real-world solutions.”
Stay uodated withย Hemostasis Today.
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer